Biomarkers and Functional Decline in Prodromal Alzheimer’s Disease

Abstract

We show that distinct baseline biomarkers may predict latent changes in IADL. Our results necessitate a revision of the commonly held view upholding cognitive changes as the predominant endpoint measure associated with presence of abnormal baseline biomarkers.